Page last updated: 2024-08-24

ziprasidone and Serotonin Syndrome

ziprasidone has been researched along with Serotonin Syndrome in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grabe, HJ; Janowitz, D; Schomerus, G; Speerforck, S1
Eisman, J; Palekar, N1
Hong, CJ; Lin, PY; Tsai, SJ1
Gitlin, MJ; Rim, CL1
Cates, ME1

Other Studies

5 other study(ies) available for ziprasidone and Serotonin Syndrome

ArticleYear
[Psychosis, Intoxication or Serotonin Syndrome? - A 20-Year Old Male with Ziprasidone und Sertraline].
    Psychiatrische Praxis, 2017, Volume: 44, Issue:8

    Topics: Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Lorazepam; Male; Piperazines; Psychotropic Drugs; Schizophrenia, Paranoid; Schizophrenic Psychology; Serotonin Syndrome; Sertraline; Substance-Related Disorders; Thiazoles; Young Adult

2017
Serotonin syndrome with ziprasidone and sertraline.
    The Journal of neuropsychiatry and clinical neurosciences, 2013,Spring, Volume: 25, Issue:2

    Topics: Adult; Female; Humans; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Syndrome; Sertraline; Thiazoles

2013
Serotonin syndrome caused by ziprasidone alone.
    Psychiatry and clinical neurosciences, 2010, Volume: 64, Issue:3

    Topics: Antipsychotic Agents; Female; Humans; Middle Aged; Piperazines; Serotonin Syndrome; Thiazoles

2010
Ziprasidone, monoamine oxidase inhibitors, and the serotonin syndrome.
    Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:4

    Topics: Adult; Depressive Disorder, Major; Drug Interactions; Female; Humans; Monoamine Oxidase Inhibitors; Piperazines; Serotonin Antagonists; Serotonin Syndrome; Thiazoles; Tranylcypromine

2010
Ziprasidone--not an option for serotonin syndrome.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2003, Nov-25, Volume: 169, Issue:11

    Topics: Antipsychotic Agents; Humans; Piperazines; Receptors, Serotonin; Serotonin Syndrome; Thiazoles

2003